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Inorganic arsenic occurring in various forms
in the environment has been classified as a
definite human carcinogen (group 1) since
1979 (International Agency for Research on
Cancer 1980). Numerous studies conducted
in Taiwan and South America found that
exposure to inorganic arsenic from drinking
water is associated with cancers of the bladder,
kidneys, skin, and other organs and tissues
(Cantor 1997; Ferreccio et al. 2000).
Similar to Taiwan, several countries in
South Asia have high levels of naturally occur-
ring arsenic in groundwater. In the early
1970s, the government of Bangladesh, with
the support and financing of the United
Nations Children’s Fund, promoted the dig-
ging of the tube wells to provide clean drink-
ing water. In the late 1990s, evidence indicated
that the groundwater, the main source of
drinking water in Bangladesh, is contaminated
by naturally occurring arsenic in 59 of the
64 districts of the country. An estimated
25–40 million of Bangladesh’s 127 million
people have been exposed to levels frequently
above the national limit of 50 ppb and often
reaching levels as high as 800 ppb (British
Geological Survey 2006).
Several studies have shown convincing evi-
dence of the association between drinking
arsenic-rich water and skin lesions, which are
recognized as precursors of nonmelanoma skin
cancer (Ahsan et al. 2006b; Guha Mazumder
et al. 1998; Tondel et al. 1999). Recent studies
conducted in South Asia have raised the possi-
bility that antioxidants may modify the effects
of water arsenic on the risk of skin lesions
(Hsueh et al. 1995; Vahter 2000). Folate and
cobalamin (vitamin B12) have been suggested
to play an important role in the detoxiﬁcation
of ingested arsenic (Gamble et al. 2005b;
Mitra et al. 2004; National Research Council
1999). Speciﬁcally, methylation of arsenic is a
folic acid–dependent reaction catalyzed by a
cobalamin-dependent enzyme (Gamble et al.
2005b; Zakharyan and Aposhian 1999).
Steinmaus et al. (2005) showed that consump-
tion of high levels of niacin (vitamin B3) was
associated with arsenic methylation. Other
studies showed some evidence that anti-
oxidants such as vitamin A also play a role in
diminishing arsenic toxicity (Chattopadhyay
et al. 2002; Hsueh et al. 1995; Roychowdhury
et al. 2003; Styblo and Thomas 2001). To
date, few studies have evaluated the effects of
diet speciﬁc to Bangladesh on the relationship
between arsenic exposure from drinking water
and skin lesions. McCarty et al. (2006)
reported a signiﬁcantly reduced risk associated
with intake of fruits and canned goods, but
were not able to assess the effects of individual
food compounds.
The Health Effects of Arsenic Longitudinal
Study (HEALS) was established to examine the
health effects of arsenic exposure in Bangladesh.
It is a population-based prospective cohort
study in Araihazar, Bangladesh, with individ-
ual-level water arsenic measurements. We
recently reported an increased dose-related risk
of skin lesions in relation to arsenic exposure in
this cohort (Ahsan et al. 2006b). As part of the
investigation, we collected detailed information
about the daily diet of all participants, using a
food frequency questionnaire (FFQ) developed
specifically for this population. The U.S.
Department of Agriculture (USDA 2006) and
Indian nutritional tables (Gopalan et al. 1996)
were used to estimate the consumption of var-
ious vitamins and antioxidants. Here, using
the baseline data of the HEALS cohort, we
report the results of analyses aimed at clari-
fying the effects of the vitamin B group,
including thiamin (vitamin B1), riboflavin
(vitamin B2), niacin (vitamin B3), pyridoxine
(vitamin B6), cobalamin (vitamin B12), and
folic acid and antioxidants (vitamins A, C,
and E) on the relationship between arsenic
exposure and skin lesions.
Materials and Methods
The detailed description of the study methods
and participants of the HEALS cohort ana-
lyzed here has been published previously
(Ahsan et al. 2006a, 2006b; Parvez et al.
2006). In brief, we identified and tested all
5,996 tube wells in the 25-km2 area of
Araihazar, Bangladesh, and proceeded to
recruit eligible cohort members from their
65,876 users. A total of 14,828 individuals
met the following eligibility criteria: married
and ≥ 18 years of age; resident in the study
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BACKGROUND: An estimated 25–40 million of the 127 million people of Bangladesh have been
exposed to high levels of naturally occurring arsenic from drinking groundwater. The mitigating
effects of diet on arsenic-related premalignant skin lesions are largely unknown.
OBJECTIVES: The purpose of this study was to clarify the effects of the vitamin B group (thiamin,
riboﬂavin, niacin, pyridoxine, and cobalamin) and antioxidants (vitamins A, C, and E) on arsenic-
related skin lesions.
METHODS: We performed a cross-sectional study using baseline data from the Health Effects of
Arsenic Longitudinal Study (HEALS), 2000–2002, with individual-level, time-weighted measures
of arsenic exposure from drinking water. A total of 14,828 individuals meeting a set of eligibility
criteria were identiﬁed among 65,876 users of all 5,996 tube wells in the 25-km2 area of Araihazar,
Bangladesh; 11,746 were recruited into the study. This analysis is based on 10,628 subjects
(90.5%) with nonmissing dietary data. Skin lesions were identiﬁed according to a structured clini-
cal protocol during screening and conﬁrmed with further clinical review.
RESULTS: Riboﬂavin, pyridoxine, folic acid, and vitamins A, C, and E signiﬁcantly modiﬁed risk of
arsenic-related skin lesions. The deleterious effect of ingested arsenic, at a given exposure level, was
signiﬁcantly reduced (ranging from 46% reduction for pyridoxine to 68% for vitamin C) for per-
sons in the highest quintiles of vitamin intake.
CONCLUSIONS: Intakes of B-vitamins and antioxidants, at doses greater than the current recommended
daily amounts for the country, may reduce the risk of arsenic-related skin lesions in Bangladesh.
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user of one of the study wells for at least
3 years. Nineteen percent of the eligible indi-
viduals (n = 2,778) were not at home during
study visits. Of the 12,050 individuals who
were available and approached, 11,746 (97.5%
response rate) were recruited to the cohort
between October 2000 and May 2002.
Informed consent was obtained from each eli-
gible respondent who agreed to participate in
the study. The study protocol and ﬁeld proce-
dures were approved by the Columbia
University Institutional Review Board and by
the Ethical Committee of the Bangladesh
Medical Research Council.
Measurement of arsenic exposure. Water
samples from all tube wells were analyzed for
arsenic concentrations by the graphite furnace
arsenic absorption method, as described previ-
ously (van Geen et al. 2003). Detailed informa-
tion about water consumption in the preceding
years from questionnaires was used to construct
the individual-level, time-weighted arsenic
(TWA) exposure measure, taking into account
both arsenic concentration and duration of
water drinking from the index tube well (Ahsan
et al. 2006a). Thus, TWA (in micrograms per
liter) = ΣCiTi/ΣTi, where Ci and Ti denote the
well arsenic concentration and drinking dura-
tion for the ith well, respectively.
All HEALS participants provided urine
samples, which were used to estimate total uri-
nary arsenic concentration by the graphite fur-
nace arsenic absorption method, as described
previously (Nixon et al. 1991). Urinary creati-
nine was analyzed using a method based on
the Jaffe reaction (Slot 1965).
Measurement of vitamins and antioxidants.
The baseline interview collected information on
diet using a semiquantitative 39-item FFQ
designed to assess the long-term usual diet of
cohort participants and described in detail else-
where (Chen et al. 2004). Briefly, HEALS
investigators, with help from local nutrition
experts, ﬁrst identiﬁed all the food items avail-
able at the village market in the study area. The
FFQ was ﬁnalized after pilot testing to include
common food items. Food items with intake
frequencies less than once per month during
the past year were deemed to be insigniﬁcant.
We are confident that the food list covers
> 90% of the typical daily diet in the study
population (Chen et al. 2004), because the
development of the food list was based on
extensive pilot work and the diet in rural
Bangladesh is relatively homogeneous and sim-
ple. Food diversity is limited by the low avail-
ability of tillable land. The average diet is
almost entirely cereal-based, comprising very
few highly processed food products. The use of
dietary/nutritional supplements is rare in
Bangladesh. The reasonable average daily
intakes of energy computed from both the FFQ
and a food diary (FD) gave reassurance on this
aspect (Chen et al. 2004). Extensive work was
done to assess the validity of the data collected
from the FFQ, including two 7-day FDs for
189 randomly selected study subjects. The lat-
ter showed moderately good correlations for
B vitamins with the FFQ; for example, energy-
adjusted correlation coefﬁcients with correction
for within-individual variation were 0.46 for
riboﬂavin, 0.39 for niacin, and 0.57 for cobal-
amin (Chen et al. 2004). Although large sea-
sonal variations between the two FDs were
observed for vitamins A and C, overall the FFQ
was deemed an adequate tool to capture long-
term intakes of common foods and nutrients in
this population (Chen et al. 2004).
Nutrient values for foods in Bangladesh
were not available. Therefore, we used the
USDA National Nutrient Database for
Standard Reference (USDA 2006) and an
Indian food nutrient database (Gopalan et al.
1996) to estimate the intake of various nutri-
ents from reported intake of foods. However,
the Indian tables lack information on several
important nutrients such as cobalamin and
vitamin E. The correlations between all other
nutrients discussed in the analysis estimated
using both sets of tables were very good, in
both males and females (Pearson’s correlation
coefﬁcients > 0.7 for all other nutrients; data
not shown). Therefore, we present the results
using the USDA tables. Individual B vitamins
were highly correlated, with Pearson’s correla-
tion coefﬁcients ranging from 0.50 for niacin
and folic acid to 0.98 for niacin and thiamin.
All nutrient values were log-transformed to
improve the normality of the distribution
(Chen et al. 2004) and were adjusted for total
energy using the residual method (Willett and
Stampfer 1986). Average daily intakes of food
groups and nutrients estimated by the FFQ in
the study population are reported in the
Appendix. 
Measurement of the outcome. A structured
protocol was used to assess skin lesion presence
during the clinical examination (Ahsan et al.
2006a). Briefly, to ensure uniformity in the
clinical examination of skin lesions across the
entire body, we instituted a structured protocol
following the plan for quantitative assessment
of the extent of body surface involvement in
burn patients. The principle is based on divid-
ing the entire body skin surface into 11 seg-
ments (e.g., front of arm, back of arm, face)
and assigning percentages to each of them
based on their size relative to the whole body
surface. Each subject was examined by a physi-
cian of the same sex, who recorded presence or
absence of the skin lesions and their size and
shape. A total of 810 cases with skin lesions
(hyperkeratosis and/or melanosis) were identi-
ﬁed among 11,746 subjects; 714 (88.1%) of
those with skin lesions were conﬁrmed upon
further clinical review [421 (337 males and
84 females) had melanosis only, and 293
(247 males and 46 females) had both hyperk-
eratosis and melanosis) (Ahsan et al. 2006b).
When we evaluated the dose-dependent effect
of arsenic separately for early-stage (melanosis)
and late-stage (hyperkeratosis) skin lesions, the
results were similar (Ahsan et al. 2006b). In the
current analysis, the modifying effects of indi-
vidual B vitamins and antioxidants did not dif-
fer by severity of skin lesions (data not shown),
and therefore all subsequent analyses are pre-
sented for all skin lesions.
Statistical analysis. Our first approach
was to compare prevalence of skin lesions in
the baseline cohort across the arsenic dose
range. Others have suggested that the effects
of many risk factors may vary among sub-
groups, depending on intake of dietary factors
(Rothman and Greenland 1998; Willett
1998). Thus, our second statistical approach
was to conduct categorical analysis of the data
using unconditional logistic regression model-
ing for Bernoulli data (Breslow and Day
1987). In the model with water arsenic con-
sumption, we estimated prevalence odds ratios
(PORs) of skin lesions in quintiles of intake of
various micronutrients. The cutpoints for
these quintiles were chosen to evenly distrib-
ute all subjects. Given reasonable assumptions
about the progression of such lesions to a clin-
ically detectable state, the POR is a good
approximation of the relative risk of skin
lesions estimated from studies that do not
involve screening (Ahsan et al. 2006b).
Most studies to date have concentrated on
evaluating whether the relative risk associated
with the main exposure of interest is constant
across categories of the third variable, that is,
under the assumption of multiplicative inter-
action (Rothman and Greenland 1998). We
used an excess relative risk (ERR) model to
estimate the ERR per unit of arsenic expo-
sure. By adding 1.0 to the ERR, we obtained
the relative risk per unit change in exposure.
This risk model has the form
γ(z0)[1 +δ (dose, βdose) ε (ze)], [1]
where γ, δ, and ε are functions of the back-
ground risks, the dose-related risks, and the
risk-modifying factors, respectively; z0 is a pos-
sible independent factor; (ze) is a risk-modify-
ing factor; and βdose is an arsenic dose
parameter (ERR) to be estimated from the lin-
ear function of dose. Adjusted parameter esti-
mates from this model can be directly (i.e.,
without exponentiation) interpreted as the
increase in risk of skin lesions per unit dose of
exposure in this population. Thus, any risk
associated with arsenic exposure multiplies the
background risk from independent risk factors
other than arsenic, such as age and education,
and the relationship between risk and arsenic
dose is linear. Furthermore, the model gives
effect estimates for the main effects of arsenic
exposure, other independent risk factors, and
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model can be used to test effect modiﬁcation
on multiplicative scale efﬁciently (with fewer
degrees of freedom), compared with methods
based on conventional stratified analysis and
the use of cross-product terms in uncondi-
tional logistic regression models.
Based on the literature review and previous
analysis of the baseline data (Ahsan et al.
2006b; Argos et al. 2007), we speciﬁed a num-
ber of a priori confounders for the arsenic–skin
lesion relationship such as sex, age (categorized
into nine 5-year categories), body mass index
(BMI; categorized into quintiles of an approxi-
mately equal number of subjects), education
(< 1, 1–6, 6–11, and > 11 years), occupation,
and television and land ownership (proxies of
socioeconomic status). Several studies (e.g.,
Chen et al. 2006; McCarty et al. 2006), includ-
ing our previous analysis of this cohort (Ahsan
et al. 2006b), have shown that the use of
tobacco products is associated with the risk of
skin lesions independently of arsenic exposure. 
We evaluated effects of consumption of
various B vitamins (thiamin, riboﬂavin, niacin,
pyridoxine, cobalamin, and folic acid) and
antioxidants (vitamins A, C, and E) on arsenic-
related skin lesions by two methods: we evalu-
ated them for independent associations with
skin lesions, and we used Equation 1 to evalu-
ate their effect-modifying properties. When
variables were evaluated as possible indepen-
dent risk factors of skin lesions, an arsenic dose
parameter was retained in the model to control
for the main effects of dose and for possible
confounding effects. Individual risk factors
were retained in the model if they signiﬁcantly
improved the ﬁt of the model, as evaluated by
the likelihood ratio test comparing the
deviances from the two nested models or if
they changed the risk estimate by more than
10%. Urinary creatinine was included in all
models analyzing the effects of urinary arsenic
as a separate independent variable (Gamble
and Liu 2005). To identify signiﬁcant inter-
action, we used the trend test assessing relative
risks across categories of micronutrient intake.
In that case, the ordinal variable was used to
represent increasing consumption categories.
Because the distributions of arsenic meas-
urements were not normal, we constructed a
standard unit of arsenic exposure to be used in
the dose–response models whereby risk was
estimated per unit of exposure deﬁned as the
interquartile range [difference between the
75th and 25th percentiles (Willett 1998)]. In
our analysis, this unit was 131 µg/L for time-
weighted water arsenic (range, 0.1–648.0 µg/L;
mean, 98.2 µg/L) and 130 µg/L for urinary
arsenic (range, 1–2273.0 µg/L; mean,
130.9 µg/L). Because the model is linear, the
ERR per unit of dose for arsenic exposure
could be converted to an ERR per 1-µg/L by
dividing the ERR by 131.
All statistical tests were two-sided with a
specified type I error of 0.05, yielding 95%
confidence intervals (CIs) estimated by the
maximum likelihood method. All analyses
were performed using the GMBO module of
the EPICURE statistical package (Preston
et al. 1993).
Study population. Of the total of 11,746
subjects recruited between October 2000 and
May 2002, 522 (4.4%) did not provide urine
samples and were excluded from this analysis.
An additional 570 (4.8%) subjects were
excluded either because there was not enough
information in the questionnaire about their
water-drinking habits to permit estimation of
individual-level, time-weighted arsenic mea-
sures or because they did not undergo a physi-
cal examination for skin lesions status.
Furthermore, 3 subjects had missing informa-
tion on land ownership, an important a priori–
deﬁned confounder, and 23 subjects had very
high levels of time-weighted arsenic measure,
which were considered outliers. Thus, all
analyses are based on the cohort of 10,628 sub-
jects (90.5% of those recruited), 658 of whom
had skin lesions and thus were considered eligi-
ble cases (92.2% of all cases).
Results
In our study, approximately 45% of subjects
consumed < 50 µg/L time-weighted water
arsenic. Study subjects with skin lesions had
significantly higher consumption compared
with those who did not develop skin lesions
(chi-square test, p < 0.001). Males were five
times more likely to have skin lesions than
females (POR = 5.4; 95% CI, 4.3–6.7)
(Table 1). Cases tended to be older and, in gen-
eral, risk of skin lesions increased monotonically
with age (p < 0.001; data not shown). A num-
ber of risk factors have been examined as meas-
ures of socioeconomic status, but only
education was a strong predictor of risk of skin
lesions in this cohort. We observed a reduced
POR for skin lesions (POR = 0.3; 95% CI,
0.2–0.6) for those with ≥ 11 years of education
compared with those who had < 1 year of for-
mal education. The association with BMI was
not linear, but higher BMIs appeared to be
inversely associated with skin lesions.
Table 2 presents the results of analyses
investigating the independent effects of various
B vitamins and other antioxidants on the risk of
skin lesions after adjustment for arsenic expo-
sure, total energy intake, and signiﬁcant con-
founders identiﬁed in Table 1 (sex, age at risk,
BMI, and education). For riboﬂavin, pyridox-
ine, vitamins A, C, and E, and folic acid, a
reduced POR for skin lesions was observed for
those in the highest quintiles of consumption
(ranging from 46% for vitamin A to 60% for
vitamin E) in risk of skin lesions.
Signiﬁcant p-values of the linear trend test
for riboﬂavin; pyridoxine; vitamins A, C, and
E; and folic acid indicated a strong linear
dose–response trend in the data. Figure 1 is a
Zablotska et al.
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Table 1. Sociodemographic characteristics of the study participants.
Cases Noncases Adjusted  PORa
Variable [no. (%)] [no. (%)] (95% CI) p-Valueb
Water arsenic (µg/L)
0.1–49.9 169 (25.7) 4,539 (45.5)
50.0–99.9 133 (20.2) 1,833 (18.4)
100.0–199.9 166 (25.2) 2,077 (20.8)
200.0–648.0 190 (28.9) 1,521 (15.3)
Sex 
Female 122 (18.5) 5,978 (60.0) 1 < 0.001
Male 536 (81.5) 3,992 (40.0) 5.4 (4.3–6.7)
Age (years)
< 25 13 (2.0) 1,020 (10.2) 1 < 0.001
25–29 24 (3.6) 1,630 (16.3) 0.8 (0.4–1.5)
30–34 62 (9.4) 1,803 (18.1) 1.5 (0.8–2.7)
35–39 101 (15.3) 1,782 (17.9) 2.0 (1.1–3.7)
40–44 114 (17.3) 1,296 (13.0) 3.0 (1.7–5.5)
45–49 124 (18.8) 1,187 (11.9) 3.6 (2–6.5)
50–54 96 (14.6) 675 (6.8) 4.0 (2.2–7.4)
55–59 77 (11.7) 393 (3.9) 4.3 (2.3–8)
≥ 60 47 (7.1) 184 (1.8) 4.6 (2.4–9)
BMI
< 17.2 177 (26.9) 1,929 (19.3) 1 0.065
17.2–18.6 165 (25.1) 2,092 (21.0) 1.0 (0.8–1.2)
18.6–20.0 133 (20.2) 1,939 (19.4) 1.1 (0.8–1.3)
20.0–22.3 102 (15.5) 2,074 (20.8) 0.8 (0.6–1.1)
≥ 22.3 81 (12.3) 1,936 (19.4) 0.8 (0.6–1.1)
Education (years)
< 1 345 (52.4) 4,429 (44.4) < 0.001
1–6 192 (29.2) 2,904 (29.1) 0.9 (0.7–1.0)
6–11 106 (16.1) 2,228 (22.3) 0.6 (0.5–0.8)
≥ 11 15 (2.3) 409 (4.1) 0.3 (0.2–0.6)
aAdjusted for time-weighted arsenic, sex, age at risk, BMI, education, and total energy intake. bLikelihood ratio test com-
paring the nested model with a model with additional variable. graphic representation of the adjusted PORs
in Table 2. It is evident that consumption of
most B vitamins, as well as antioxidants, was
inversely associated with risks of skin lesions,
as shown by downward sloping lines. The
effects of thiamin, riboflavin, niacin, and
cobalamin were less pronounced, and their
estimates for various quintiles of consumption
hovered around the null effect. Therefore, we
did not evaluate the arsenic-modifying effects
of these vitamins in the subsequent analyses.
In our cohort, intake of riboflavin
strongly correlated with the intake of pyridox-
ine and folic acid (Pearson’s correlation coefﬁ-
cients 0.75 and 0.83, respectively; data not
shown). When we investigated the combined
independent effects of these three micro-
nutrients by simultaneously entering them
into the model, we observed slight attenua-
tion of effect of arsenic-related skin lesions,
but the reduction in risk in the upper quin-
tiles of micronutrient consumption compared
with the lowest quintile remained unchanged
(data not shown).
Table 3 shows that after adjusting the
background rates for sex, age at risk, education,
BMI, and total energy consumption, those
consuming water containing 131 µg/L time-
weighted water arsenic had an ERR of skin
lesions of 1.6 (95% CI, 1.0– 2.1); that is, for
every 131-µg/L increase of time-weighted
water arsenic, we observed a 2.6-fold higher
risk of skin lesions. The effects of arsenic expo-
sure were modified by consumption of vita-
mins. Table 3 shows that intake of riboﬂavin
(model 2) was a strong modiﬁer of the effects
of arsenic. Those in the highest quintile of con-
sumption had only 37% of the ERR (1.0 per
131 µg/L; 95% CI, 0.5–1.8) of those in the
lowest quintile (ERR = 2.7 per 131 µg/L; 95%
CI, 0.2–3.8). Similarly, intakes of folic acid
(model 4) and vitamins A, C, and E (models
6–8) modiﬁed the arsenic-related skin lesion
risks, with reductions of ERR estimates for
skin lesions in the highest quintiles (compared
with the lowest quintiles of micronutrient
intake) ranging from 65 to 68%.
To estimate the combined effect of B vita-
mins on arsenic-related skin lesions, we
repeated our analyses with simultaneous inter-
action terms for riboflavin, pyridoxine, and
folic acid. We observed that those in the high-
est quintiles of consumption of all three micro-
nutrients had only 37.8% of the ERR of those
in the lowest quintiles of consumption for all
three nutrients (ERR, 3.2 per 131 µg/L
weighted water arsenic exposure) (model 5).
Thus, on the basis of these results and those
presented in Tables 2 and 3, it appears that the
effects of the B vitamins are additive in nature.
We further investigated the effects of uri-
nary arsenic, which was strongly correlated
with the time-weighted arsenic exposure meas-
ure used in Table 3 (Pearson’s r = 0.47; data
not shown). Similar to the analysis of the time-
weighted arsenic exposure measure presented
in Table 2, only riboflavin; pyridoxine; vita-
mins A, C, and E; and folic acid displayed an
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Table 2. PORs and 95% CIs for the effects of B vitamins and antioxidants on risk of skin lesions.
Vitamin, energy-adjusted
values (quintiles) Adjusted PORa 95% CI p-Valueb
Thiamin (mg/day)
< 1.62 1 0.162
1.62–1.91 1 0.7–1.7
1.92–2.19 0.6 0.4–1.2
2.20–2.50 0.6 0.3–1.2
≥ 2.51 0.5 0.2–1.2
Riboﬂavin (mg/day)
< 0.69 1 < 0.001
0.69–0.82 0.7 0.6–1.0
0.83–0.96 0.6 0.4–0.8
0.97–1.16 0.6 0.4–0. 8
≥ 1.17 0.5 0.3–0.7
Niacin (mg/day)
< 23.48 1 0.365
23.48–28.67 1.1 0.6–2.0
28.68–32.44 1.0 0.5–2.1
32.45–37.97 1.5 0.6–3. 6
≥ 37.98 1.0 0.3–2.6
Pyridoxine (mg/day)
< 2.72 1 0.001
2.72–3.17 0.8 0.5–1.1
3.18–3.65 0.5 0.3–0. 8
3.66–4.18 0.3 0.2–0.6
≥ 4.19 0.4 0.2–0.8
Cobalamin (mg/day)
< 0.84 1 0.200
0.84–1.30 0.8 0.6–1.1
1.31–1.80 1.0 0.8–1.3
1.81–2.53 0.8 0.6–1.0
≥ 2.54 0.8 0.6–1.1
Folic acid (µg/day)
< 196.64 1 < 0.001
196.64–240.63 0.6 0.4–0.8
240.64–283.99 0.5 0.4–0.7
284.00–351.60 0.5 0.3–0.7
≥ 351.61 0.5 0.3–0.6
Vitamin A (mg/day)
< 2298.48 1 < 0.001
2298.48–3503.45 0.7 0.5–0.8
3503.46–4886.75 0.7 0.5–1.0
4886.76–7113.05 0.7 0.5–0.9
≥ 7113.06 0.5 0.4–0.7
Vitamin C (mg/day)
< 52.57 1 < 0.001
52.57–71.62 0.7 0.5–0.9
71.63–92.67 0.5 0.3–0.6
92.68–126.16 0.4 0.3–0.6
≥ 126.17 0.4 0.3–0.6
Vitamin E (mg/day)
< 4.06 1 < 0.001
4.06–4.79 0.5 0.3–0.7
4.80–5.52 0.5 0.4–0.7
5.53–6.40 0.4 0.3–0.6
≥ 6.41 0.4 0.3–0.6
aAdjusted for time-weighted water arsenic, sex, age at risk, BMI, education, and total energy intake. bTest of homogene-
ity of PORs across quintiles of micronutrient intake. 
Figure 1. PORs for quintiles of vitamin intake from
the categorical analysis. 
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inverse effect on the risk of skin lesions (data
not shown). Table 4 shows that, on average,
ERRs associated with the urinary arsenic con-
centrations were > 3-fold higher than those
associated with the water arsenic. Furthermore,
riboﬂavin; pyridoxine; vitamins A, E, and C;
and folic acid modify the effects of urinary
arsenic. These effects are in the same direction
(albeit stronger) as the effects observed for the
time-weighted arsenic exposure measure in
Table 3, with reductions in risk of skin lesions
in the upper quintiles of vitamins intake rang-
ing from 34 to 74%.
Discussion 
In this article we report the results of analysis
of the baseline data from the prospective
cohort study of the association between time-
weighted water arsenic exposure and risk of
skin lesions. Although skin lesions have been
linked previously with exposure to arsenic-
contaminated drinking water, there is a recog-
nized lack of information on the modifying
effects of local diet on this relationship
(McCarty et al. 2006). To our knowledge,
this is the ﬁrst systematic analysis of the asso-
ciation between micronutrient intake and
prevalence of arsenic-induced skin lesions.
We estimated an ERR of 1.6 (95% CI,
1.0–2.1) per 131-µg/L time-weighted water
arsenic and an ERR of 4.91 (95% CI, 1.8–8.1)
per 130-µg/L urinary arsenic concentration.
Thus, those exposed to a dose equal to 50 µg/L
water arsenic, the currently permissible arsenic
limit in Bangladesh (and in the United States,
until recently), had a 59% higher risk of skin
lesions compared with those with dose zero.
Even a small dose of water arsenic equal to the
current water arsenic concentration limit in the
United States of 10 µg/L carried a 12% increase
in risk compared with those with zero doses.
We found that riboﬂavin; pyridoxine; vita-
mins A, C, and E; and folic acid were signiﬁ-
cant strong modiﬁers of the effects of ingested
arsenic. Our results suggest that consumption
of a diet rich in these vitamins and anti-
oxidants can signiﬁcantly reduce the harmful
effects of water arsenic on the development of
skin lesions. Those in the highest percentile of
consumption had a significant reduction in
risks, ranging from 46% (ERR decreased from
Table 4. Modiﬁcation of effect of urinary arsenic on skin lesions by B vitamins
and antioxidants.
Variable, energy-adjusted
Modela values (quintiles) ERRb 95% CI p-Valuec
1 Urinary arsenic (µg/L)  4.9 1.8–8.1
2 Riboﬂavin (mg/day)
< 0.69 9.0 3.4–14.5 < 0.001
0.69–0.82 5.6 3.9–7.8
0.83–0.96 4.3 3.0–6.3
0.97–1.16 3.6 2.4–5.5
≥ 1.17 2.8 1.7–4.4
3 Pyridoxine (mg/day)
< 2.72 10.7 2.7–18.7 < 0.001
2.72–3.17 7.6 5.0–11.7
3.18–3.65 4.2 2.5–7.2
3.66–4.18 2.8 1.5–5.5
≥ 4.19 4.0 2.0–7.9
4 Folic acid (µg/day)
< 196.64 10.6 3.8–17.5 < 0.001
196.64–240.63 6.0 4.3–8.2
240.64–283.99 4.9 3.4–6.9
284.00–351.60 4.2 2.9–6.0
≥ 351.61 3.9 2.7–5.7
5 Vitamin A (mg/day)
< 2298.48 8.1 2.8–13.5 < 0.001
2298.48–3503.45 4.9 3.5–6.7
3503.46–4886.75 5.8 4.2–7.8
4886.76–7113.05 5.4 3.9–7.3
≥ 7113.06 3.4 2.4–4.9
6 Vitamin C (mg/day)
< 52.57 12.2 4.2–20.1 < 0.001
52.57–71.62 7.6 5.6–10.0
71.63–92.67 4.1 2.9–5.8
92.68–126.16 4.4 3.2–6.2
≥ 126.17 4.1 2.9–6.0
7 Vitamin E (mg/day)
< 4.06 11.6 3.9–19.4 < 0.001
4.06–4.79 4.6 3.1–6.9
4.80–5.52 4.8 3.0–7.3
5.53–6.40 3.5 2.1–5.7
≥ 6.41 3.3 1.9–5.6
aEstimates of effect adjusted for sex, age at risk, BMI, education, urinary creatinine,
and total energy intake. bERR of arsenic-related skin lesions per 130-µg/L urinary
arsenic for quintiles of micronutrient intake. cTrend test using ordinal variable to repre-
sent increasing quintiles of micronutrient intake. 
Table 3. Modification of effect of water arsenic on skin lesions by B vitamins
and antioxidants.
Variable, energy-adjusted
Modela values (quintiles) ERRb 95% CI p-Valuec
1 Water arsenic (µg/L)  1.6 1.0–2.1
2 Riboﬂavin (mg/day)
< 0.69 2.7 0.2–3.8 0.010
0.69–0.82 2.0 1.3–3.1
0.83–0.96 1.3 0.8–2.2
0.97–1.16 1.4 0.8–2.3
≥ 1.17 1.0 0.5–1.8
3 Pyridoxine (mg/day)
< 2.72 2.4 1.2–3.6 0.054
2.72–3.17 2.2 1.3–3.7
3.18–3.65 1.3 0.7–2.5
3.66–4.18 0.8 0.4–1.8
≥ 4.19 1.3 0.7–2.7
4 Folic acid (µg/day)
< 196.64 3.2 1–4.4 < 0.001
196.64–240.63 1.8 1.2–2.8
240.64–283.99 1.3 0.8–2.1
284.00–351.60 1.2 0.7–1.9
≥ 351.61 1.1 0.7–1.8
5 Combined model:
riboﬂavin (mg)/pyridoxine (mg)/folic acid (µg)
< 0.69/< 2.72/< 196.64 3.2 1.6–4.9 0.005
0.69–0.82/2.72–3.17/196.64–240.63 2.2 0.9–3.5
0.83–0.96/3.18–3.65/240.64–283.99 1.1 0.3–1.9
0.97–1.16/3.66–4.18/284.00–351.60 0.9 0.3–1.6
≥ 1.17/≥ 4.19/≥ 351.61 1.2 0.5–2.0
6 Vitamin A (mg/day)
< 2298.48 2.6 1.7–3.6 < 0.001
2298.48–3503.45 1.2 0.8–2.0
3503.46–4886.75 1.7 1.1–2.6
4886.76–7113.05 1.7 1.1–2.6
≥ 7113.06 0.9 0.5–1.5
7 Vitamin C (mg/day)
< 52.57 3.4 2.3–4.6 < 0.001
52.57–71.62 2.0 1.4–2.9
71.63–92.67 1.2 0.7–1.9
92.68–126.16 1.1 0.7–1.7
≥ 126.17 1.1 0.7–1.8
8 Vitamin E (mg/day)
< 4.06 3.4 1.9–4.9 0.002
4.06–4.79 1.3 0.8–2.2
4.80–5.52 1.5 0.9–2.5
5.53–6.40 1.2 0.6–2.1
≥ 6.41 1.2 0.6–2.1
aModels adjusted for sex, age at risk, BMI, education, and total energy intake. bERR of
arsenic-related skin lesions per 131-µg/L time-weighted water arsenic for quintiles of
micronutrient intake. cTrend test using ordinal variable to represent increasing quintiles of
micronutrient intake. 2.4 to 1.3) for pyridoxine to 68% (ERR
decreased from 3.4 to 1.1) for vitamin C, at a
given level of arsenic exposure (Table 3).
It is noteworthy that in our population,
the consumption of riboflavin, pyridoxine,
and vitamin A were significantly lower than
the RDA values for India (Gopalan et al.
1996) (data not shown). For example, the rec-
ommended daily amount for both males and
females for pyridoxine is 2 mg, but our cohort
members consumed, on average, 0.66 and
0.61 mg/day (males and females, respectively).
Vitamin consumption was better for folic acid
and vitamin C. In our study, the potential
protective modifying effects of these vitamins
were restricted within the medium and upper
quartiles of consumption. Thus, it appears
that beneﬁcial effects of riboﬂavin; pyridoxine;
vitamins A, C, and E; and folic acid are associ-
ated with consumption of amounts greater
than the current recommended daily amounts
for the population.
Among the major strengths of the present
study are use of individual-level, time-
weighted water arsenic measures, micronutri-
ent measure from a validated instrument, and
the large size of the study population. Caution
should be exercised while interpreting these
ﬁndings, as they are based on numerous com-
parisons and could be due to chance. In addi-
tion, our analyses are based on the prevalent
skin lesions. We are continuing follow-up of
the cohort and will analyze the data on the
incident skin lesion identiﬁed during the ﬁrst
and second two-yearly follow-up visits. The
use of FFQ introduced inevitable measure-
ment errors. If present, this measurement error
would attenuate the association (bias it toward
the null effect). Future studies with biochemi-
cal measures of nutrient intakes, especially for
vitamins A, C, and E, are needed to further
evaluate the effects of these nutrients.
The evidence on the health effects of
arsenic from food is limited. Although several
studies have documented arsenic contents in
rice collected in arsenic-affected areas
(Misbahuddin 2003; Roychowdhury et al.
2003), the bioavailability of arsenic from rice
and other food items is not known. The ﬁnd-
ings of the present study would not be affected
by the potential role of arsenic in rice, as rice is
not the main source of the nutrients found to
have a modifying effect. If arsenic in rice
indeed has an effect on skin lesions, the mea-
surement error in total arsenic exposure may
lead to a bias toward the null for the observed
dose–response relationship. Furthermore,
arsenic in food is considered to be present
largely in organic forms, and the content
depends on the arsenic concentration in the
soil as well as in the water used for washing,
cooking, and irrigation (Roychowdhury et al.
2003). Future studies are needed to consider
the potential role of arsenic in food items.
Finally, many participants drank water from
the same well (59.2% of study participants
drank from a well with ≥ 3 subjects/well,
31.9% from a well with two study subjects/
well, and the remaining 8.9% of subjects from
individual wells), making well water arsenic
concentration a shared characteristic. These
correlated errors arising from shared wells
would affect the width of the CIs, but should
not affect the magnitudes or directions of the
point estimates.
Methylation of arsenic, a hypothesized
detoxiﬁcation pathway, requires the conversion
of S-adenosylmethionine to S-adenosylhomo-
cysteine and depends partly on the one-carbon
metabolism in which riboflavin, pyridoxine,
cobalamin, and folic acid all play a role (Selhub
2002). Previous studies have shown that intake
of vitamins inﬂuences the efﬁciency of arsenic
methylation (McCarty et al. 2006; Steinmaus
et al. 2005). Our ﬁndings that riboﬂavin, pyri-
doxine, and folic acid modiﬁed the risk of skin
lesions are consistent with the hypothesis that
individuals with insufﬁcient intakes of nutrients
related to arsenic metabolism are more suscepti-
ble to the health effect of arsenic exposure.
These ﬁndings further suggest that riboﬂavin,
pyridoxine, and folic acid may play a more
important role in modifying arsenic toxicity.
Although folic acid is readily available in
many food items, its deﬁciency is not uncom-
mon, primarily because naturally occurring
folates are highly susceptible to oxidative degra-
dation, for example, during cooking (Gamble
et al. 2005b). We reported previously that
there is a high prevalence of folate deﬁciency
and hyperhomocysteinemia in Araihazar,
Bangladesh (Gamble et al. 2005a) and that
these conditions are associated with reduced
arsenic methylation (Gamble et al. 2005b).
Intracellular antioxidants such as vitamins
A, C, and E decrease arsenic toxicity by revers-
ing disturbances in lipid peroxidation, genera-
tion of nitric oxide, reactive oxygen species, and
apoptosis initiated by arsenic metabolites
(Chattopadhyay et al. 2002; National Research
Council 1999). β-Carotene may also scavenge
free-radical species (Krinsky 1989). Previous
studies have shown that low serum levels of
carotene modiﬁed the effect of arsenic exposure
on the risk of ischemic heart disease (Hsueh
et al. 1998). Several studies have found that
Dietary modifiers of arsenic-related skin lesions
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Appendix. Average daily intakes of food groups and nutrients estimated by the FFQ.a
Food group Food item Mean ± SD (g/day) Nutrientsb Mean ± SD
Milk Milk 25.44 ± 45.51 Energy (kJ) 2285.94 ± 621.23
Rice Puffed rice 19.56 ± 28.31 Total fat (g) 24.22 ± 9.35
Steamed rice 1568.27 ± 524.14 Monounsaturated fat (g) 8.11 ± 3.52
Water rice 26.09 ± 78.85 Polyunsaturated fat (g) 6.75 ± 1.9
Bread Wheat bread (brown) 17.41 ± 46.65 Saturated fat (g) 5.81 ± 3.17
Tea Tea 63.68 ± 173.67 Cholesterol (mg) 101.92 ± 89.76
Meat Beef or mutton 14.89 ± 25.69 Protein (g) 72.84 ± 21.3
Beans Lentil  78.13 ± 84.81 Carbohydrate (g) 447.17 ± 124.86
Beans (scarlet runner) 36.42 ± 24.99 Fiber (g) 43.49 ± 11.79
Potato Potato 110.06 ± 91.46 Thiamin (mg) 2.09 ± 0.55
Sweet potato 4.81 ± 8.12 Riboﬂavin (mg) 0.95 ± 0.33
Poultry Poultry (duck or fowl) 3.54 ± 11.48 Niacin (mg) 31.14 ± 8.55
Vegetables Cabbage 9.24 ± 14.62 Pyridoxine (mg) 3.49 ± 0.97
Cauliﬂower 21.89 ± 17.44 Folate (µg) 281.08 ± 111.23
Eggplant 13.45 ± 25.39 Cobalamin (mg) 1.81 ± 1.26
Squash Ghosala  4.61 ± 7.89 Retinol equivalents (mg) 294.36 ± 221.58
Bitter gourd  8.35 ± 11.64 Vitamin C (mg) 96.05 ± 64.68
Bottle gourd  19.06 ± 21.77 Vitamin E (mg) 5.35 ± 1.66
Ridge gourd  4.09 ± 7.3 Calcium (mg) 367.6 ± 126.52
Snake gourd  6.74 ± 8.24 Copper (mg) 2.4 ± 0.64
Parwar 6.72 ± 10.89 Iron (mg) 12.78 ± 3.81
Okra 8.00 ± 10.66 Magnesium (mg) 854.44 ± 235.16
Green papaya 6.16 ± 16.08 Manganese (mg) 16.51 ± 4.73
Pumpkin 3.03 ± 7.49 Potassium (mg) 2701.95 ± 950.83
Radish 14.12 ± 17.2 Selenium (mg) 189.93 ± 53.38
Spinach 17.08 ± 28.38 Sodium (mg) 434.12 ± 285.15
Spinach stalks 12.76 ± 17.55 Zinc (mg) 13.7 ± 3.88
Tomato 52.82 ± 47.48
Yam 9.44 ± 15.94
Jack fruit 17.14 ± 25.37
Mango 30.76 ± 52.2
Watermelon 4.38 ± 13.43
Eggs Eggs (hen eggs)  7.85 ± 15.47
Fish Big ﬁsh (fresh water) 22.68 ± 23.5
Dry ﬁsh 1.96 ± 5.22
Salted ﬁsh 0.37 ± 2.24
Small ﬁsh (fresh water) 29.06 ± 28.12
aFor 10,628 study participants included in the analysis. bUSDA nutrient database (USDA 2006). Zablotska et al.
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prevalence of vitamin A deﬁciency is high in
Bangladesh (Ahmed 1999), possibly explaining
the important modifying effect of vitamin A
observed in this study. Given that vitamin A
consumption in the Bangladeshi diet is mostly
from plant sources, the correlation between
beta carotene intake and vitamin A in our study
was nearly perfect (r = 0.99), explaining the
similarity of modifying effects of vitamin A and
beta carotene on arsenic-related skin lesions.
Overall malnutrition, defined as either a
general calorie deficit or a diet adequate in
calories but nutritionally poor, is an important
cofactor in arsenic poisoning affecting the tim-
ing and the intensity of arsenic-related prob-
lems. Guha Mazumder et al. (1998) showed
that subjects with lower BMIs had higher
prevalence of arsenic skin lesions compared
with subjects with similar arsenic exposures but
higher BMIs. Similarly, in our previous analy-
sis of this cohort, we showed that study sub-
jects with lower BMIs were at increased risk of
skin lesions (Ahsan et al. 2006b). Current
analysis indicates that BMI has an independent
effect on the development of skin lesions, and
thus, subjects with lower consumption of vita-
mins and antioxidants had higher risk of skin
lesions, indicating signiﬁcant effects of individ-
ual nutrients beyond what can be explained by
general calorie intake.
Findings on the modifying effect of sun-
light exposure on arsenic-related skin lesions
have been described elsewhere (Chen et al.
2006). Because women in Bangladesh univer-
sally wear traditional dresses that almost com-
pletely cover the skin of their trunk, sunlight
exposure of female respondents was considered
minimal and therefore was not assessed in the
study. In men, we observed an additive effect of
higher arsenic exposure and excessive sunlight
exposure, such that the risk of skin lesions asso-
ciated with any given level of arsenic exposure
was greater in males with excessive sun expo-
sure. In the present analysis, we empirically
assessed whether sunlight exposure is a potential
confounder. Adjustment for sunlight exposure
did not change the effect estimate and therefore
we did not include it in the model.
Conclusion
The results of this study strongly suggest that
consumption of foods rich in vitamins such as
riboﬂavin; pyridoxine; vitamins A, C, and E;
and folic acid may inﬂuence the relationship
between exposure to water arsenic and subse-
quent risk of skin lesions. Those in the highest
quintiles of consumption had significant
reductions in risks for skin lesions associated
with arsenic exposure. The observed modifying
effects were associated with consumption of
nutrients at doses that are higher than the
current recommended daily amounts for the
country. These ﬁndings support the hypothesis
that nutrients relevant to arsenic metabolism
and antioxidant nutrients may modify the risk
of arsenic-related skin lesions in Bangladesh.
Future studies looking at that influence of
micronutrients on risk of incident arsenic-
related skin lesions are necessary to clarify the
nature of the association. Intervention studies
are also needed to determine whether dietary
supplementation may mediate health effects of
arsenic exposure.
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